Fuad Ismail

Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

Joong‐Won Park, Richard S. Finn, Jun Suk Kim et al. · Clinical Cancer Research · 2011 · 143 citations

Medicine, Oncology, Pharmacology +13

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)

Dmytro Trukhin, Elena Poddubskaya, Zoran Andrić et al. · BioDrugs · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +14

Quality of life of women with breast cancer in a tertiary referral university hospital

Jamilah Yusoff, Aniza Ismail, Mohd Rizal Abd Manaf et al. · Health and Quality of Life Outcomes · 2022 · 28 citations · Full text

Pharmacy, Oncology, Breast Oncology +16

Closing the global cancer divide- performance of breast cancer care services in a middle income developing country

E. N. Aina, Soon Keat Cheah, Fuad Ismail et al. · BMC Cancer · 2014 · 26 citations · Full text

Medicine, Oncology, Surgery +17

Tissue-Engineered Skin Substitute Enhances Wound Healing after Radiation Therapy

Shiplu Roy Chowdhury, Fuad Ismail, Aminuddin Bin Saim et al. · Advances in Skin & Wound Care · 2016 · 25 citations

Engineering, Radiation Oncology, Surgery +16